Ongoing government and healthcare industry initiatives clearly indicate that information technology will be the driver for change in healthcare. As systems proliferate, healthcare organizations grapple with issues of whether to choose best-of-breed systems or standardize around one vendor. For many years, HCA Inc. has been a major proponent of standardization to help meet its financial and patient safety objectives. This article examines HCA's experience and explores how standardization has been a major factor in the company's financial and clinical success, enabling faster implementation, greater quality control and significant cost-savings.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Providing 'professionalism with compassion'; how the time for caring communication can improve experiences at the end-of-life at home, findings from a realist evaluation.
BMC Palliat Care
December 2024
University of Northumbria at Newcastle, Newcastle Upon Tyne, England.
Background: For many patients and caregivers, attending to dying and death at home will be a new and fearful experience. This research brings new evidence on the central support of the Rapid Response Service (RRS), provided to those who chose to die at home. RRS's are variable, although all seek to avoid unwanted hospital admissions and to respond flexibly to suit individual preferences for support.
View Article and Find Full Text PDFMetabolic Consequences of Thyroidectomy and Patient-Centered Management.
J Clin Med
December 2024
Miami Cancer Research Center, Miami, FL 33181, USA.
Thyroidectomy has been post-operatively managed by hormone replacement therapy in order to satisfy the reference ranges of thyroid stimulating hormone (TSH) and thyroxine (T4) levels. While medication and standardized reference ranges have proven to be effective, many patients continue to report unintentional weight gain despite adequate amounts of treatment and levels of TSH and T4. Physicians, over the years, have become complacent to these "normal" ranges, and have ignored the metabolic consequences that are affecting thyroidectomy patients.
View Article and Find Full Text PDFBuilding a FAIR data ecosystem for incorporating single-cell transcriptomics data into agricultural genome to phenome research.
Front Genet
November 2024
Department of Animal Science, Bioinformatics and Computational Biology Program, Iowa State University, Ames, IA, United States.
Introduction: The agriculture genomics community has numerous data submission standards available, but the standards for describing and storing single-cell (SC, e.g., scRNA- seq) data are comparatively underdeveloped.
View Article and Find Full Text PDFThe impact of dual-enrolee (Medicare/Medicaid) status on venous leg ulcer outcomes: a retrospective study.
J Wound Care
December 2024
Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Hempstead, NY, US.
Article Synopsis
- The study aimed to analyze the impact of race, sex, comorbidities, and Medicaid status on health outcomes for patients with hard-to-heal venous leg ulcers (VLUs), comparing Medicare-only beneficiaries to Medicare/Medicaid dual-enrollees from October 2015 to October 2019.
- Using Medicare claims data, the research focused on treatment methods, demographic comparisons, and quantified outcomes like ulcer closure time and quality of life metrics, finding notable differences between the two groups.
- Results showed that dual-enrollees had a higher burden of comorbidities, greater representation from minority backgrounds, and significantly increased rates of emergency visits and cellulitis compared to Medicare-only enrollees, with early use of certain
Comparison of Standard and Extended Dexamethasone Duration on Mortality in Patients with Severe COVID-19.
South Med J
December 2024
Department of Pulmonology, HCA Healthcare/USF Morsani GME Consortium: HCA Florida Citrus Hospital, Inverness.
Objectives: Current guidelines recommend dexamethasone 6 mg/day for up to 10 days in patients with severe coronavirus disease 2019 (COVID-19) requiring supplemental oxygenation or mechanical ventilation. The practice has significant variation, however, and dexamethasone has been used for >10 days for many patients with severe COVID-19. The aim of this study was to assess the benefits and risks associated with standard versus extended use of dexamethasone in patients with severe COVID-19.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!